1. "Elsevier Inc."
Formats
  1. Journal Article (7386)
  2. Meeting Abstract (4694)
  3. Review (617)
  4. Book Section (538)
  5. Editorial (250)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (240)
  2. 2024 (784)
  3. 2023 (762)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2610)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (967)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (524)
  6. Journal of Sexual Medicine (435)

More Publications

Publishers
  1. Elsevier Inc. (13855)

Results (13855)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reclassification of resected non-small cell lung carcinomas originally diagnosed as squamous cell carcinoma, after reevaluation using immunohistochemical analysis (P40, P63, TTF-1, and napsin A): Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Kadota, K.; Nitadori, J.; Rusch, V. W.; Rekhtman, N.; Sarkaria, I. S.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Tumor budding and nuclear grade, but not histologic subtype, are significant prognostic factors, independent of TNM stage, in patients with lung squamous cell carcinoma
    Meeting Abstract

    Kadota, K.; Nitadori, J.; Finley, D. J.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)
    Meeting Abstract

    Hellmann, M. D.; Wynne, M.; Wang, L.; Kris, M. G.; Sima, C. S.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • "Intention-to-treat" outcomes of sequential patients with stage IIIA lung adenocarcinomas treated with neoadjuvant chemotherapy with intent of surgical resection
    Meeting Abstract

    Hellmann, M. D.; Chaft, J. E.; Hilden, P. D.; Rusch, V. W.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Gerber, N. K.; Yamada, Y.; Shi, W. J.; Zhang, Z. G.; Riely, G.; Beal, K.; Yu, H. A.; Chan, T. A.; Rimner, A.; Wu, A. J.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Preliminary clinical safety and activity of MK-3475 monotherapy for the treatment of previously treated patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Garon, E. B.; Balmanoukian, A.; Hamid, O.; Hui, R. N.; Gandhi, L.; Leighl, N.; Gubens, M. A.; Goldman, J.; Lubiniecki, G. M.; Lunceford, J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 dose escalation study of a new ALK inhibitor, CH5424802/RO5424802, in ALK+ non-small cell lung cancer (NSCLC) patients who have failed crizotinib (AF-002JG/NP28761, NCT01588028)
    Meeting Abstract

    Gadgeel, S.; Ou, S. H.; Chiappori, A. A.; Riely, G.; Lee, R. M.; Garcia, L.; Sato, J.; Yokoyama, S.; Tanaka, T.; Gandhi, L.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
    Meeting Abstract

    Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Histological prognostic markers in squamous cell carcinoma of the lung
    Meeting Abstract

    Drilon, A.; Sima, C. S.; Paik, P. K.; Moreira, A. L.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save